S&C Advises BofA Securities, J.P. Morgan Securities, M&T Securities, Morgan Stanley, Raymond James, UBS, and Wells Fargo on M&T’s $600 Million Preferred Stock Offering

Sullivan & Cromwell LLP represented multiple underwriters in M&T Bank Corporation’s $600 million public offering of its Perpetual 6.625% Non-Cumulative Preferred Stock, now listed on the NYSE as ‘MTBPrL.’

Read More

Supreme Court of Canada Upholds Pharmascience Inc. Dosage Regimen Patent, Confirms Medical Treatment Methods Remain Unpatentable

The Supreme Court of Canada upheld Pharmascience Inc.’s dosage regimen patent while reaffirming that methods of medical treatment are not patentable, clarifying patent protection boundaries for the pharmaceutical industry.

Read More

Hogan Lovells Cadwalader Advises Axis Capital, HDFC Bank, ICICI Securities, Kotak Mahindra Capital, and SBI Capital Markets on US$400 Million Indo-MIM IPO

Hogan Lovells Cadwalader provided legal counsel to underwriters for Indo-MIM Limited’s US$400 million IPO, supporting various sectors with precision-engineered components and leveraging extensive market knowledge in India.

Read More